Anesthesiology. 82(2):383–392, FEBRUARY 1995

PMID: 7856897

Issn Print: 0003-3022

Publication Date: February 1995


Share this on facebook   Share this on Twitter   Share this on LinkedIn   Email this article  



Print

The Dose-Response Relationship of Tranexamic Acid

Jan Horrow;Daniel Van Riper;Michael Strong;Karl Grunewald;Jonathan Parmet;

+ Author Information


    loading  Checking for direct PDF access through Ovid

Abstract

BackgroundProphylactic administration of the antifibrinolytic drug tranexamic acid decreases bleeding and transfusions after cardiac operations. However, the best dose of tranexamic acid for this purpose remains unknown. This study explored the dose-response relationship of tranexamic acid for hemostatic efficacy after cardiac operation.MethodsIn prospective, randomized, double-blinded fashion, 148 patients undergoing cardiac operation with extracorporeal circulation were divided into six groups: a placebo group and five groups receiving tranexamic acid in loading doses before incision (range 2.5 to 40 mg *symbol* kg sup -1) and one-tenth the loading dose hourly for 12 h. The mass of blood collected by chest tubes over 12 h represented blood loss. Allogeneic transfusions within 12 h and within 5 d of surgery were tallied.ResultsThe six groups presented similar demographics. Patients receiving placebo had increased postoperative D-dimer concentration compared to groups receiving tranexamic acid. Patients receiving at least 10 mg *symbol* kg sup -1 tranexamic acid followed by 1 mg *symbol* kg sup -1 *symbol* h sup -1 bled significantly less (365, 344, and 369 g *symbol* 12 h sup -1, respectively, for those three groups) compared with patients who received placebo (522 g, P < 0.05). Tranexamic dose did not affect transfusions. Only initial hematocrit affected whether a patient received an allogeneic transfusion within 5 days of operation (odds ratio 2.08 for each 3% absolute decrease in hematocrit).ConclusionsProphylactic tranexamic acid, 10 mg *symbol* kg1 followed by 1 mg *symbol* kg sup -1 *symbol* h sup -1, decreases bleeding after extracorporeal circulation. Larger doses do not provide additional hemostatic benefit.

Related Topics

    Related Articles

        loading  Loading Related Articles